Halozyme Therapeutics (HALO) Tops Q2 EPS by 14c, Offers Guidance

Go back to Halozyme Therapeutics (HALO) Tops Q2 EPS by 14c, Offers Guidance
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 69.45 -1.28 (1.81%)
Previous Close $70.73    52 Week High $18.39 
Open $71.01    52 Week Low $6.96 
Day High $71.81    P/E N/A 
Day Low $69.33    EPS $-0.58 
Volume 169,964